Table 3.
Baseline characteristics of patients with silent CAD vs those without silent CAD
| Baseline characteristics | Positive CT scans |
Negative CT scans |
||||
|---|---|---|---|---|---|---|
| Total (n = 13) | Male (n = 10) | Female (n = 3) | Total (n = 52) | Male (n = 32) | Female (n = 20) | |
| Age (y ± SD) | 55 ± 10 | 54 ± 8 | 61 ± 15 | 53 ± 7 | 54 ± 7 | 52 ± 6 |
| BMI (kg/m2 ± SD) | 23 ± 3 | 23 ± 3 | 21 ± 2 | 24 ± 2.9 | 25 ± 3.1 | 23 ± 1.7 |
| Marathon experience | ||||||
| Lifetime full marathons (n ± SD) | 17 ± 13 | 21 ± 14 | 7 ± 5 | 11 ± 14 | 13 ± 12 | 9 ± 16 |
| Lifetime half marathons (n ± SD) | 21 ± 18 | 18 ± 18 | 32 ± 16 | 16 ± 15 | 17 ± 15 | 17 ± 14 |
| Training mileage (miles/wk ± SD) | 33 ± 13 | 33 ± 13 | 32 ± 16 | 34 ± 13 | 37 ± 13 | 30 ± 13 |
| Marathon time (h:min:s ± SD) | 4:27:39 ± 1:21:16 | 4:24:39 ± 1:21:18 | 4:37:42 ± 2:23:05 | 4:32:34 ± 1:18:18 | 4:33:33 ± 1:18:18 | 5:30:34 ± 1:19:16 |
| Cardiovascular risk factors | ||||||
| Known CAD, n (% cohort) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) |
| Hypertension, n (% cohort) | 0 (0) | 0 (0) | 0 (0) | 5 | 2 | 3 |
| Dyslipidemia, n (% cohort) | 4 (31) | 3 (30) | 1 (33) | 8 (15) | 5 (16) | 3 (15) |
| Diabetes, n (% cohort) | 0 (0) | 0 (0) | 0 (0) | 1 (1) | 1 (3) | 0 (0) |
| Family history of premature CAD, n (% cohort) | 3 (23) | 2 (20) | 1 (33) | 7 (13) | 4 (13) | 3 (15) |
| Current smoker, n (% cohort) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) |
Data are expressed as mean ± SD.
BMI, body mass index; CAD, coronary artery disease; CT, computed tomography; SD, standard deviation.